IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Phase 2 biotech developing oral small molecule therapies for autoimmune diseases.
Industry: Health Care
Latest Trade: $2.58 -0.17 (-6.3%)
First Day Return: -25.0%
Return from IPO: -82.8%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 01/13/2021 |
Offer Price | $16.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 6.3 |
Deal Size ($mm) | $100 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 02/03/2021 |
Offer Price | $16.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 6.3 |
Deal Size ($mm) | $100 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
J.P. Morgan |
Jefferies |
more |
Company Data | |
---|---|
Headquarters | Blacksburg, VA, United States |
Founded | 2017 |
Employees | 33 |
Website www.landosbiopharma.com |